Policy Name Effective Date Updated Review Date
Hematology/Oncology
MP-038 Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) February 16, 2022 February 16, 2022 February 16, 2023
MP-042 Electric Tumor Treatment Field Therapy for the Treatment of Glioblastoma Multiforme April 20, 2022 April 20, 2022 April 20, 2023